Torrent Pharma consolidated PAT at Rs 316 cr. in Q2FY22
Torrent Pharmaceuticals Limited has reported consolidated financial results for the period ended September 30, 2021
Torrent Pharmaceuticals Limited has reported consolidated financial results for the period ended September 30, 2021
Torrent is one of India's fastest-growing pharma majors
The company posted net profit of Rs.321 crores for the period ended June 30, 2020.
The agreement will help ensure wider reach and access to patients in India
The NPPA has capped prices for 41 drug combinations including diabetes, cholesterol, and sleep disorder treatments
Pregabalin Gel 8% is a novel topical solution for diabetic neuropathic pain
Prior to joining Eris, Ranganathan was Commercial Director, Women's Health, Metabolics, and International Business at Abbott India Limited
Sarat Kumar has been appointed as CFO of the company and also designated as Key Managerial Personnel with effect from February 21, 2025
e brings over 27+ years of rich pharmaceutical experience
The company is assessing the situation and simultaneously undertaking all the requisite action
Subscribe To Our Newsletter & Stay Updated